文献速递胃肠外科围术期管理与 ERAS

袖状胃切除术后转化代谢减重手术:MBSAQIP分析

Conversion metabolic bariatric surgery after sleeve gastrectomy: an MBSAQIP analysis.
PubMed 文献 · Surg Endosc · 2026-01-06

基于MBSAQIP数据库2020-2021年回顾性分析18179例袖状胃切除术后转化手术,其中85%转为RYGB;转为BPD/DS和SADI-s的轻微并发症较低(1.4-1.5%),转为RYGB、RYGB-d和OAGB的再入院率较高(19-20%),主要并发症无显著差异。

要点

  • 袖状胃切除术后转化手术常见指征为GERD和减重不足或体重反弹。
  • 转为BPD/DS和SADI-s的轻微并发症显著低于转为RYGB、RYGB-d和OAGB。
  • 转为RYGB、RYGB-d和OAGB的再入院率高于转为BPD/DS和SADI-s。

核心结论

  • 袖状胃切除术后因GERD或减重效果不佳而需要转化手术的情况日益增多。
  • 不同转化术式的主要并发症相当,但转为RYGB、RYGB-d和OAGB的再入院率和轻微并发症更高。

研究设计与样本

  • 回顾性分析2020-2021年MBSAQIP数据库,纳入袖状胃切除术后转化代谢减重手术患者。

主要发现

  • 共18179例转化手术,其中转为BPD/DS 1153例(6.3%),RYGB 15425例(85%),RYGB-d 685例(3.7%),SADI-s 723例(3.9%),OAGB 193例(1.1%)。
  • 转为BPD/DS和SADI-s的轻微并发症为1.4-1.5%,显著低于转为RYGB、RYGB-d和OAGB的2.5-2.8%(p=0.012)。
  • 主要并发症在各转化术式间无统计学显著差异(p=0.41)。
  • 转为RYGB、RYGB-d和OAGB的再入院率为19-20%,高于转为BPD/DS和SADI-s的14-15%(p<0.001)。

临床怎么用

  • 临床决策转化术式时,除主要并发症外,应关注再入院率和轻微并发症的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conversion Metabolic Bariatric Surgery (cMBS) is increasingly common despite the effectiveness of primary bariatric surgery for obesity and the medical conditions associated with obesity. OBJECTIVES: This study used the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, a retrospective national database, to analyze trends in cMBS following sleeve gastrectomy and compare postoperative outcomes among different types of conversions. SETTING: American College of Surgeons MBSAQIP Centers of Excellence across the United States. METHODS: A retrospective analysis of the 2020-2021 MBSAQIP database was performed, inclusive of patients who underwent cMBS from sleeve gastrectomy to biliopancreatic diversion with duodenal switch (BPD/DS), Roux-en-Y gastric bypass (RYGB), Roux-en-Y distal gastric bypass (RYGB-d), single-anastomosis duodeno-ileal bypass sleeve (SADI-s), and one-anastomosis gastric bypass (OAGB). Descriptive analyses and multivariable logistic regression models were performed to analyze 30-day outcomes. RESULTS: Out of 18,179 conversions from sleeve gastrectomy, 1,153 (6.3%) were to BPD/DS, 15,425 (85%) to RYGB, 685 (3.7%) to RYGB-d, 723 (3.9%) to SADI-s, and 193 (1.1%) to OAGB. Common indications included gastroesophageal reflux disease (GERD) and inadequate weight loss or weight gain. Minor complications were significantly lower (p = 0.012) for cMBS to BPD/DS and SADI-s (1.4-1.5%), compared with RYGB, RYGB-d, and OAGB (2.5-2.8%), with no statistically significant differences in major complications (p = 0.41). Readmission rates were higher for cMBS to RYGB, RYGB-d, and OAGB (19-20%), compared to BPD/DS and SADI-s (14-15%) (p < 0.001). CONCLUSIONS: cMBS are increasingly needed due to GERD or suboptimal weight outcomes. While major complications appear comparable across conversion types, RYGB, RYGB-d, OAGB have higher rates of readmissions and minor complications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Salas-Parra RD, Del Rio MB, Jou K, et al. Conversion metabolic bariatric surgery after sleeve gastrectomy: an MBSAQIP analysis. Surg Endosc. 2026. PMID: 41495488. doi:10.1007/s00464-025-12495-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。